Radiation Oncologists’ Role in Promoting Person-Centered Care in the Curative and Palliative Settings - 2021 Annual Meeting
The course begins with case studies involving suboptimal multidisciplinary care, which translates into detrimental effects for the patients involved.
Rachel Jimenez, MD will discuss the ethical principles underlying person-centered care (autonomy, beneficence, non-maleficence, justice), in the context of our encounters with individual patients, health care systems, and our responsibilities to society. This will include a discussion of how patient experiences, shared decision-making, and the informed consent process are shaped not only by individual physicians, but by how well a multidisciplinary team functions as a unit.
Karen Hoffman, MD will discuss how radiation oncologists can bring a person-centered experience to the curative setting, with an emphasis on approaches to integrating radiation oncologists into multidisciplinary clinics and establishing relationships with other providers that enables patients to meet with a radiation oncologist prior to undergoing definitive treatment for their malignancy.
Tracy Balboni, MD will then discuss how radiation oncologists can bring a person-centered experience to the palliative setting, with an emphasis on facilitating timely referrals, building relationships with palliative care physicians, and incorporating goals of care into treatment decisions. In each of these presentations there will be further discussion on being a good role model for person-centered treatment approaches in our decisions on the radiation-treatment modality and dose-fractionation used, following the patients we treat, helping to manage recurrences and side effects, and approaches to shared decision-making in different clinical contexts.
Finally, Malcolm Mattes, MD will present pathways for educating peers in other specialties about radiation oncology, as well as practical interventions to raise awareness about radiation oncology.
This activity is available from December 13, 2021, through 11:59 p.m. Eastern time on December 12, 2024.
This activity was originally recorded at ASTRO’s 2021 Annual Meeting, October 24-27th.
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.
Upon completion of this activity, participants should be able to:
- Develop multidisciplinary clinics that include radiation oncologists at their institution, and educate their colleagues in other specialties about the value of radiation therapy in patient care.
- Form good working relationships with surgeons, medical oncologists, and palliative care physicians, and be a better role model for patient-centered care in their hospital and community.
- Michael L. Steinberg, MD is employed University of California Los Angeles and has investment interest from ViewRay and Kurtin Capital.
- Rachel B. Jimenez, MD is employed Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School and has no financial relationships with a commercial interest.
- Karen E. Hoffman, MD is employed Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center and receives compensation/remuneration/funding from from Janssen and Varian Medical Systems.
- Tracy Anne Balboni, MD is employed Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute and receives compensation/remuneration/funding from the Templeton Foundation.
- Malcolm D Mattes, MD is employed Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.